Release 9.1 of the open, interoperable enterprise platform for omics-based patient and compound profiling provides valuable new features for precision medicine research and development teams. Translational research scientists, bioinformaticians, biologists and analysts, among others, benefit from smooth integration of existing processes, faster workflow implementation, tougher security measures and improved opportunities for collaboration.
(PRWeb November 03, 2015)
Read the full story at http://www.prweb.com/releases/2015/11/prweb13056960.htm
For more information, please visit
http://www.prweb.com/releases/2015/11/prweb13056960.htm